Drugs Made In America Acquisition Corp. Rights share price logo

Drugs Made In America Acquisition Corp. Rights

NASDAQ: DMAAR

Small Cap

$0.10

(+-2.14%)

Live

as on

Drugs Made In America Acquisition Corp. Rights Stock Performance

as on May 6, 2026 at 1:14 am IST

  • Day's High

    $0.10
    $0.11

    10.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.04
    $0.24
    downward going graph

    60.00%

    Downside

    143.30%

    Upside

    downward going graph

Drugs Made In America Acquisition Corp. Rights share price movements today

Previous Close
$0.11
Open
$0.11
Volume
30.6K
Day's Low - High
$0.10 - $0.11
52 Week Low - High
$0.04 - $0.24

Drugs Made In America Acquisition Corp. Rights Historical Returns

1 Month Return
+ 78.83 %
3 Month Return
-23.36 %
1 Year Return
-17.46 %
3 Year Return
0 %
5 Year Return
0 %

Drugs Made In America Acquisition Corp. Rights Stock Fundamentals & Key Indicators

Check Drugs Made In America Acquisition Corp. Rights market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Drugs Made In America Acquisition Corp. Rights stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Drugs Made In America Acquisition Corp. Rights with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$1.8MNANA0.00%

Stock Returns calculator for Drugs Made In America Acquisition Corp. Rights Stock including INR - Dollar returns

The Drugs Made In America Acquisition Corp. Rights stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Drugs Made In America Acquisition Corp. Rights investment value today

Current value as on today

₹86,948

Returns

-₹13,052

(-13.05%)

Returns from Drugs Made In America Acquisition Corp. Rights Stock

-₹23,077 (-23.08%)

Dollar Impact

₹10,025 (+10.02%)

Drugs Made In America Acquisition Corp. Rights Stock’s Investor Sentiment and Interest

Search interest for Drugs Made In America Acquisition Corp. Rights Stock has increased by 58% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:58% versus previous 30 day period

Insights on Drugs Made In America Acquisition Corp. Rights

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, DMAAR stock has moved up by 19.4%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, DMAAR has outperformed top 5 stocks with highest market-cap in its industry

About Drugs Made In America Acquisition Corp. Rights

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.
OrganisationDrugs Made In America Acquisition Corp. Rights
Headquarters1 East Broward Boulevard, Fort Lauderdale, FL, United States, 33301
IndustryMiscellaneous
CEOMr. Roger Bendelac
E-voting on sharesClick here to vote

Key Management of Drugs Made In America Acquisition Corp. Rights

Name

Title

Mr. Roger Bendelac

Chief Executive Officer

Mr. Saleem Elmasri CPA

CFO & Principal Accounting Officer

FAQs

What is Drugs Made In America Acquisition Corp. Rights share price today?

Drugs Made In America Acquisition Corp. Rights share price today is $0.1 as on . Drugs Made In America Acquisition Corp. Rights share today touched a day high of $0.11 and a low of $0.1.

What is the 52 week high and 52 week low for Drugs Made In America Acquisition Corp. Rights share?

Drugs Made In America Acquisition Corp. Rights share touched a 52 week high of $0.24 on and a 52 week low of $0.04 on . Drugs Made In America Acquisition Corp. Rights stock price today i.e. is trending at $0.1,which is 58.90% down from its 52 week high and 150.00% up from its 52 week low.

What is Drugs Made In America Acquisition Corp. Rights's market capitalisation today?

Drugs Made In America Acquisition Corp. Rights market capitalisation is $0.00T as on .

How to invest in Drugs Made In America Acquisition Corp. Rights Stock (DMAAR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Drugs Made In America Acquisition Corp. Rights on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Drugs Made In America Acquisition Corp. Rights Shares that will get you 15.0000 shares as per Drugs Made In America Acquisition Corp. Rights share price of $0.1 per share as on May 5, 2026 at 7:44 pm IST.

What is the minimum amount required to buy Drugs Made In America Acquisition Corp. Rights Stock (DMAAR) from India?

Indian investors can start investing in Drugs Made In America Acquisition Corp. Rights (DMAAR) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Drugs Made In America Acquisition Corp. Rights stock (as per the Rupee-Dollar exchange rate as on ). Based on Drugs Made In America Acquisition Corp. Rights share’s latest price of $0.1 as on May 5, 2026 at 7:44 pm IST, you will get 100.0000 shares of Drugs Made In America Acquisition Corp. Rights. Learn more about fractional shares .